Novotech Wins 2024 Clinical Trials Arena Excellence Award for Business Development and Innovation

Novotech, a full-service global contract research organization (CRO), has been honored with multiple awards at the 2024 Clinical Trials Arena Excellence Awards. These prestigious accolades recognize Novotech’s achievements in business development, innovation, and marketing, underscoring the company’s commitment to advancing…

Read MoreNovotech Wins 2024 Clinical Trials Arena Excellence Award for Business Development and Innovation

Mirum Pharmaceuticals Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced that on November 8, 2024, its Compensation Committee granted inducement awards to seven new employees under the company’s 2020 Inducement Plan. These awards consist of non-qualified stock options to purchase 56,100 shares of common…

Read MoreMirum Pharmaceuticals Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)

Cencora Expands Specialty Leadership with Acquisition of Retina Consultants of America

Cencora, Inc. (NYSE: COR), a global leader in pharmaceutical solutions, today announced it has entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading management services organization (MSO) for retina specialists, from Webster Equity Partners. The…

Read MoreCencora Expands Specialty Leadership with Acquisition of Retina Consultants of America

Castle Biosciences to Present New Data on DecisionDx®-Melanoma and MyPath® Melanoma at ASDP 61st Annual Meeting

Castle Biosciences, Inc. (Nasdaq: CSTL), a leader in developing innovative tests to guide patient care, will present new data on the clinical performance of its DecisionDx®-Melanoma and MyPath® Melanoma tests at the 61st Annual Meeting of the American Society of…

Read MoreCastle Biosciences to Present New Data on DecisionDx®-Melanoma and MyPath® Melanoma at ASDP 61st Annual Meeting